SCHEMBL24258667

SCHEMBL24258667

COP(S)OCC1CCC(n2cnc(C)c2/N=c2/[nH]ccn2C=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258568 0.69 ALDH1A1 (0.39) —
SCHEMBL24258681 0.67 KCNJ1 (0.30) —
SCHEMBL20927136 0.64 BCHE (0.51) —
SCHEMBL24559517 0.58 ALDH1A1 (0.36) —
SCHEMBL22524086 0.57 ALDH1A1 (0.48) —
SCHEMBL20692032 0.56 ALDH1A1 (0.38) —
SCHEMBL17232078 0.55 ALDH1A1 (0.43) —
SCHEMBL12567150 0.55 BCHE (0.47) —
SCHEMBL21626046 0.54 BCHE (0.51) —
SCHEMBL21540015 0.54 ALDH1A1 (0.73) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752516-B1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL MYERS SQUIBB CO (US) 2022-02-23 — — EP disclosed
Send feedback